Managed Care Calendar

  • ACC 59th Annual Scientific Session
    Start Date: 
    March 14, 2010
    End Date: 
    March 16, 2010
  • PCMA PBM Summit
    Start Date: 
    March 15, 2010
    End Date: 
    March 17, 2010
  • AMCP's 22nd Annual Meeting & Showcase
    Start Date: 
    April 7, 2010
    End Date: 
    April 10, 2010

Poll

Current Issue

  • Issue: 
    February 2010

    With Legislation Stalled, Reformers Regroup

    Confronted with public opposition, a unified minority party, and an election loss that changed the balance of power in the US Senate, healthcare reform efforts have entered a new phase featuring talk of bipartisan cooperation and a healthcare summit at the White House. Democrats continue to hold majorities in the House of Representatives and the Senate, but after months of debate and several narrowly won votes, their voluminous healthcare bills may no longer be viable. The opposition is calling for reformers to toss out the current Hous

  • Issue: 
    February 2010

    CMS Report Depicts Government’s Increasing Role

    Spending on healthcare in the United States totaled $2.5 trillion in 2009, a 5.7% increase, and accounted for 17.3% of the nation’s gross domestic product (GDP). Although job losses contributed to a reduction in private insurance enrollment, insurers saw better growth in private health insurance premiums than during 2008. Growth in public-sector healthcare spending outpaced increases in private outlays, and the government’s share of the national healthcare bill is projected to exceed 50% by 2012, according to projections rele

  • Issue: 
    February 2010

    In the discussion of healthcare reform in the United States, primary care physicians have been focused on as the point practitioners in the drive to deliver higher-quality care and to lower costs. Meanwhile, patient populations have increased, growing older and more complex, while net income for primary care physicians dropped by 10.2% between 1995 and 2003. Studies have indicated that greater patient satisfaction is associated with perceived and actual visit duration, and that a poor provider relationship may lead to lesser medication adherence.

  • Issue: 
    February 2010

    Philadelphia—Golimumab inhibited progression of radiographic damage to joints in patients with psoriatic arthritis (PSA), according to 52-week results of the randomized, controlled the GO-REVEAL (Golimumab-Randomized Evaluation of Safety and Efficacy in Subjects with Psoriatic Arthritis Using a Human Anti-TNF Monoclonal Antibody) study reported at the ACR meeting. Arthur F. Kavanaugh, MD, of the University of California San Diego presented results a late-breaking news session.